Sat 20 April 2024
Warszawa (PL)
7/5°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
8 |
10 |
9 |
6 |
9 |
Sat 20 April 2024
Praha (CZ)
5/4°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
11 |
9 |
7 |
9 |
9 |
Sat 20 April 2024
Bratislava (SK)
8/5°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
12 |
11 |
11 |
10 |
10 |
Sat 20 April 2024
Budapest (HU)
8/5°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
14 |
14 |
13 |
12 |
12 |
May 12th, 2020
Hungarian researchers have concluded the first phase of developing favipiravir, a medication proven effective against cases of the novel coronavirus in Asia. Production of the drug might start as early as this autumn, the innovation and technology ministry said on Tuesday. The infrastructure for clinical tests and manufacturing will be provided by a wide-ranging cooperation between the government, research institutes, universities and companies, the ministry said.
MTI
Pageviews this month:
32,595